American Society of Hematology

SHERPA: Blue

People

  1. Mcdevitt
    Mcdevitt
  2. Scheinberg
    Scheinberg
  3. Pandit-Taskar
    Pandit-Taskar
  4. Ballangrud-Popovic
    Ballangrud-Popovic
  5. Carrasquillo
    Carrasquillo
  6. Humm
    Humm
  7. O'Reilly
    O'Reilly
  8. Wong
    Wong
  9. Benezra
    Benezra
  10. Blasberg
    Blasberg

Groups

  1. Center for Hematologic Malignancies (13)
  2. GSK Faculty (13)
  3. Hematologic Malignancies Research (13)
  4. Molecular Pharmacology and Chemistry Program Faculty (13)
  5. Radiochemistry and Imaging Sciences Service (13)
  6. Radiology, Department of (13)
  7. Sloan Kettering Institute Faculty (13)
  8. Tow Center for Developmental Oncology (TCDO) (13)
  9. Adult Leukemia (12)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
Search Within
  1. "Radiochemistry and Imaging Sciences Service"
  2. "Blood"
  3. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (13)
  2. GSK Faculty (13)
  3. Hematologic Malignancies Research (13)
  4. Molecular Pharmacology and Chemistry Program Faculty (13)
  5. Radiochemistry and Imaging Sciences Service (13)
  6. Radiology, Department of (13)

More Groups

People
  1. David Scheinberg (12)
  2. Michael Mcdevitt (12)
  3. Steven Larson (8)
  4. Joseph Jurcic (7)
  5. Ronald Finn (5)
  6. Chaitanya Divgi (4)

More People

Years
  1. 2022 (1)
  2. 2011 (1)
  3. 2009 (2)
  4. 2008 (1)
  5. 2007 (1)
  6. 2004 (2)

More Years

Publications
  1. Blood (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fructose treatment targets myeloid leukemogenesis in IDH2 mutants by exhausting alpha-ketoglutarate pools
    Meeting Abstract

    Savino, A. M.; Turner, B.; Jeong, S.; Schild, T.; Yang, X.; Luo, H.; Chirayil, R.; Cullen, Q.; Chan, M.; Han, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Vascular endothelial-cadherin targeted alpha-particle mediated vascular killing and remodeling augments subsequent chemotherapeutic efficacy
    Meeting Abstract

    Escorcia, F. E.; Henke, E.; McDevitt, M. R.; Villa, C.; Smith-Jones, P.; Blasberg, R.; Benezra, R.; Scheinberg, D. A.
    Blood (2009)

    Fulltext@MSK | Save
  • Multivalent DNA aptamer-based therapeutic agents for lymphoma and leukemia
    Meeting Abstract

    Mallikaratchy, P.; Ruggiero, A.; Maguire, W.; Piersanti, K.; Gardner, J.; Villa, C.; Escorcia, F.; Palomba, M. L.; Heaney, M.; McDevitt, M. R.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers
    Journal Article

    Yuan, R. R.; Wong, P.; McDevitt, M. R.; Doubrovina, E.; Leiner, I.; Bornmann, W.; O'reilly, R.; Pamer, E. G.; Scheinberg, D. A.
    Blood (2004)

    Fulltext@MSK | Save
  • Clonal deletion of CD8(+) T cells by alpha emitting suicide peptide/MHC tetramers
    Meeting Abstract

    Yuan, R. R.; Wong, P.; McDevitt, M. R.; Antczak, C.; Doubrovina, E.; Leiner, I.; Guirnalda, P.; Borella, C. P.; Bornmann, W.; O'reilly, R.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save